SFI
RLAY icon

Susquehanna Fundamental Investments’s Relay Therapeutics RLAY Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+19,575
New +$284K 0.01% 619
2026
Q1 		– Sell
-54,993
Closed -$465K – 665
2025
Q4 		$465K Sell
54,993
-65,279
-54% -$466K 0.02% 437
2025
Q3 		$628K Sell
120,272
-158,940
-57% -$606K 0.02% 406
2025
Q2 		$966K Sell
279,212
-76,953
-22% -$229K 0.03% 452
2025
Q1 		$933K Buy
356,165
+9,877
+3% +$38.7K 0.01% 706
2024
Q4 		$1.43M Buy
+346,288
New +$1.88M 0.02% 619
2024
Q2 		$348K Buy
53,442
+38,117
+249% +$260K 0.01% 760
2024
Q1 		$127K Buy
+15,325
New +$150K 0.01% 644
2022
Q4 		– Sell
-12,401
Closed -$277K – 1437
2022
Q3 		$277K Buy
+12,401
New +$272K ﹤0.01% 1180
2022
Q1 		$211K Buy
+7,051
New +$171K ﹤0.01% 1352
2021
Q4 		– Sell
-7,300
Closed -$230K – 1717
2021
Q3 		$230K Buy
+7,300
New +$246K ﹤0.01% 1494
2021
Q2 		– Sell
-11,548
Closed -$399K – 1759
2021
Q1 		$399K Sell
11,548
-20,322
-64% -$882K 0.01% 1217
2020
Q4 		$1.32M Sell
31,870
-7,037
-18% -$318K 0.02% 759
2020
Q3 		$1.66M Buy
+38,907
New +$1.48M 0.05% 492

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Susquehanna Fundamental Investments's RLAY Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 19,575 shares worth $366K. The stake represents 0.01% of the portfolio and ranks #619 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in RLAY as recently as Q4 2025.

Susquehanna Fundamental Investments first reported a position in RLAY in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.66M in Q3 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Susquehanna Fundamental Investments held 19,575 shares of Relay Therapeutics worth $366K as of Q2 2026.
  • Relay Therapeutics was a new Susquehanna Fundamental Investments position in Q2 2026.
  • Relay Therapeutics made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #619 holding.
  • Susquehanna Fundamental Investments first reported a position in Relay Therapeutics in Q3 2020 and has held it in 14 quarters since.
  • Susquehanna Fundamental Investments's Relay Therapeutics position peaked at $1.66M in Q3 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.